One big pharma, can not cover NVGN

if even half, of these potentials are to be researched / succeed. I'am basing that on Dr. Gunnings comment.

There is no one company, that could research all the potentials. Yes, i'am saying maybe think a multi-pharma deal at some point. NVGN will own the manufacturing, patents, etc...

Dr. Stein said last year they identified 200 ATM's alone and had a "hit", on 3 so far, with a goal of 5. Looking like, NVGN is securing everything, ahead of the FDA/clinical party.

Manufacturing, methods of delivery, drug of choice and who knows whatever else is involved ( i sure the hell don't), in the total IP package with this stuff. Wow

Glta!
Chris